EXG102 and EXG202 are investigational gene therapy candidates for wet age-related macular degeneration that are in ...
The acquisition creates a clinical-stage company focused on the development of gene therapy treatments for rare inherited retinal degenerations.
Beacon Therapeutics presented 3-month interim safety and efficacy data from the Phase 2 DAWN trial of laru-zova (AGTC-501) for X-linked retinitis pigmentosa (XLRP) at the FLORetina ICOOR 2024 meeting ...
DelveInsight has released a report entitled, “Diabetic Macular Edema Market Insights, Epidemiology, and Market Forecast-2034.″ This report is a detailed look at diabetic macular edema (DME) ...
Researchers described the presence of multiple bilateral serous retinal detachments (SRDs) found in 3 women after they used ...
It is noteworthy that patients with mild TBI often report visual issues despite normal results of visual acuity measurements ...
Nerve cells in the retina were analyzed at the Vienna University of Technology using microelectrodes. According to researchers, the nerve cells demonstrated surprisingly stable behavior, which is good ...
The authors searched PubMed, Scopus, MEDLINE, ScienceDirect, and ClinicalTrials.gov, and selected studies based on reports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback